Across TCGA patient cohorts, RPL9P16 RNA expression is significantly associated with the protein abundance of many other proteins, with 12,222 significant associations in total. PDAC shows the largest number of these associations.

The most reproducible RPL9P16-associated proteins across cancer lineages are PALLD, PALLD_S641, and ENAH. Each is linked with RPL9P16 in more than 6 cancer types. Because this analysis shows association rather than direction, both RPL9P16-to-partner and partner-to-RPL9P16 results are reported.

Each partner links to its own Q-omics profile.

RNA expression associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (RPL9P16→partner) and Y-score (partner→RPL9P16) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner protein	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
CCRCC	PALLD →	+0.672	+0.343	<.001	<.001	3	7
HNSC	PALLD_S641 →	+1.272	+1.096	<.001	<.001	3	7
HNSC	ENAH →	+0.504	+0.888	<.001	<.001	3	6
CCRCC	CALD1 →	+0.527	+0.326	<.001	<.001	3	5
PDAC	CNN3 →	+0.479	+0.664	<.001	<.001	3	5
LSCC	DENND2B →	+0.376	+0.996	<.001	<.001	3	5

Each partner links to its Q-omics profile. Showing the 6 strongest of 12,222 associations by consensus.

Exploration

RPL9P16 survival (RNA) · tumor vs normal (RNA) · all RPL9P16 data types